Objective Rosuvastatin plus ezetimibe improves the lipid-lowering effect through different mechanisms of action. This study intended to compare the efficacy and safety of the fixed-dose combination (FDC) of rosuvastatin/ezetimibe vs.
Xianyou Ji +35 more
doaj +1 more source
Ezetimibe and vascular endothelial function. [PDF]
Hypercholesterolemia is a major risk factor for cardiovascular diseases that has been managed mostly with 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) that suppress de novo cholesterol synthesis in the liver.
Maemura, Koji, Ikeda, Satoshi
core
Pengembangan Sistem Dispersi Padat Ezetimibe dengan Matriks PEG 8000 menggunakan Metode Peleburan [PDF]
Ezetimibe termasuk pada Biopharmaceutics Classification Sistem (BCS) kelas II yang memiliki kelarutan yang rendah, sehingga laju disolusi dan bioavailabilitas oralnya rendah.
Rahayyu, Annisa Maulidia
core
FIXED COMBINATION ATORVASTATIN-EZETIMIBE (ATOZET(R))
peer reviewedCardiovascular prevention in subjects at high or very high risk requires a drastic reduction in LDL cholesterol according to the concept "the lower, the better".
Scheen, André
core
Association between perioperative statin-ezetimibe therapy and reoperation following arthroscopic rotator cuff repair: A TriNetX database study. [PDF]
Mahatme R +7 more
europepmc +1 more source
Liver enzyme elevations during statin-ezetimibe therapy in <i>ABCG2</i> c.421C>A variant carriers: a case series and narrative review. [PDF]
Šimičević L +6 more
europepmc +1 more source
Comparative biomarker efficacy of cholesteryl ester transfer protein inhibitors: a network meta-analysis. [PDF]
Banach M +10 more
europepmc +1 more source
Ezetimibe Versus Alirocumab and Plaque Vulnerability in Patients with Acute Coronary Syndrome Not Achieving LDL-Cholesterol Target with Statin Therapy: The COMBI-LLT-ACS Randomized Trial. [PDF]
Kovalskaya A +5 more
europepmc +1 more source
Deciphering the Mechanisms of Statin-Ezetimibe Drug Combinations Using Boolean Logical Modeling and Transcriptomic Data. [PDF]
Wang RS +5 more
europepmc +1 more source
Optimizing Cardiovascular Risk in PLWH: Real-World Efficacy and Lipid Kinetics of Fixed-Dose Combination Rosuvastatin Ezetimibe. [PDF]
Falasca K +8 more
europepmc +1 more source

